• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation.肺癌风险预测:前列腺癌、肺癌、结直肠癌和卵巢癌筛查试验模型及其验证。
J Natl Cancer Inst. 2011 Jul 6;103(13):1058-68. doi: 10.1093/jnci/djr173. Epub 2011 May 23.
2
Predictors of adverse smoking outcomes in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.前列腺癌、肺癌、结直肠癌和卵巢癌筛查试验中不良吸烟结局的预测因素。
J Natl Cancer Inst. 2012 Nov 7;104(21):1647-59. doi: 10.1093/jnci/djs398. Epub 2012 Oct 26.
3
Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.用于选择曾经吸烟者进行CT肺癌筛查的风险模型的开发与验证
JAMA. 2016 Jun 7;315(21):2300-11. doi: 10.1001/jama.2016.6255.
4
Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.随机前列腺癌、肺癌、结直肠癌和卵巢癌(PLCO)癌症筛查试验中的肺癌筛查。
J Natl Cancer Inst. 2010 May 19;102(10):722-31. doi: 10.1093/jnci/djq126. Epub 2010 May 4.
5
Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.用于选择肺癌筛查候选者的风险预测模型:一项回顾性验证研究。
PLoS Med. 2017 Apr 4;14(4):e1002277. doi: 10.1371/journal.pmed.1002277. eCollection 2017 Apr.
6
Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study.采用简约集成机器学习模型评估肺癌筛查的资格:一项开发和验证研究。
PLoS Med. 2023 Oct 3;20(10):e1004287. doi: 10.1371/journal.pmed.1004287. eCollection 2023 Oct.
7
Prediction of true positive lung cancers in individuals with abnormal suspicious chest radiographs: a prostate, lung, colorectal, and ovarian cancer screening trial study.胸部X光片异常可疑个体中真正阳性肺癌的预测:一项前列腺癌、肺癌、结直肠癌和卵巢癌筛查试验研究。
J Thorac Oncol. 2009 Jun;4(6):710-21. doi: 10.1097/JTO.0b013e31819e77ce.
8
Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.采用风险模型进行肺癌筛查的研究对象选择(泛加拿大肺癌早期检测[PanCan]研究):一项单臂前瞻性研究。
Lancet Oncol. 2017 Nov;18(11):1523-1531. doi: 10.1016/S1470-2045(17)30597-1. Epub 2017 Oct 18.
9
Lung Cancer Risk and Demographic Characteristics of Current 20-29 Pack-year Smokers: Implications for Screening.当前吸烟量为20-29包年的人群的肺癌风险及人口统计学特征:对筛查的启示
J Natl Cancer Inst. 2015 Oct 19;107(11). doi: 10.1093/jnci/djv226. Print 2015 Nov.
10
Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial.基于前列腺、肺、结肠直肠和卵巢癌筛查试验以及国家肺癌筛查试验参与者的肾细胞癌风险估计。
Urol Oncol. 2016 Apr;34(4):167.e9-16. doi: 10.1016/j.urolonc.2015.10.011. Epub 2015 Nov 18.

引用本文的文献

1
Assessment and recalibration of seventeen lung cancer risk prediction models in approximately one million Chinese population utilising healthcare big data: a retrospective cohort analysis.利用医疗大数据对约100万中国人群中的17种肺癌风险预测模型进行评估与重新校准:一项回顾性队列分析
Lancet Reg Health West Pac. 2025 May 16;58:101575. doi: 10.1016/j.lanwpc.2025.101575. eCollection 2025 May.
2
Performance of volume and diameter thresholds in malignancy prediction of solid nodules in lung cancer screening.肺癌筛查中实性结节恶性预测的体积和直径阈值性能
Thorax. 2025 Aug 15;80(9):624-631. doi: 10.1136/thorax-2024-222086.
3
Incidence rate and malignancy risk in new nodules in a lung cancer screening programme.肺癌筛查项目中新发结节的发病率及恶性风险
Eur Radiol. 2025 Apr 24. doi: 10.1007/s00330-025-11576-3.
4
Assessing the risk of second primary lung cancer in women after previous breast cancer.评估既往患乳腺癌女性发生第二原发性肺癌的风险。
BJC Rep. 2025 May 15;3(1):33. doi: 10.1038/s44276-025-00151-4.
5
Impact of Low-Dose Computed Tomography Findings on Cigarette Smoking Cessation Among High-Risk Adults Participating in Lung Cancer Screening.低剂量计算机断层扫描结果对参与肺癌筛查的高危成年人戒烟的影响。
Nicotine Tob Res. 2025 Jul 22;27(8):1412-1419. doi: 10.1093/ntr/ntaf010.
6
Predictive performance of risk prediction models for lung cancer incidence in Western and Asian countries: a systematic review and meta-analysis.西方国家和亚洲国家肺癌发病风险预测模型的预测性能:一项系统评价和荟萃分析。
Sci Rep. 2025 Mar 4;15(1):4259. doi: 10.1038/s41598-024-83875-6.
7
Uptake and 4-week outcomes of an 'opt-out' smoking cessation referral strategy in a London-based lung cancer screening setting.在伦敦的肺癌筛查环境中,“选择退出”戒烟转诊策略的接受情况及4周结果。
BMJ Open Respir Res. 2025 Feb 6;12(1):e002337. doi: 10.1136/bmjresp-2024-002337.
8
Impact of Comorbidities on the Mortality Benefits of Lung Cancer Screening: A Post-Hoc Analysis of the PLCO and NLST Trials.合并症对肺癌筛查死亡率获益的影响:PLCO和NLST试验的事后分析
J Thorac Oncol. 2025 May;20(5):565-576. doi: 10.1016/j.jtho.2025.01.003. Epub 2025 Jan 9.
9
Analysis of Lung Cancer Incidence in Non-Hispanic Black and White Americans using a Multistage Carcinogenesis Model.使用多阶段致癌模型分析非西班牙裔黑人和白人美国人的肺癌发病率。
Cancer Causes Control. 2025 Mar;36(3):285-296. doi: 10.1007/s10552-024-01936-7. Epub 2024 Nov 19.
10
Current Evidence for a Lung Cancer Screening Program.肺癌筛查项目的当前证据。
Port J Public Health. 2024 Apr 22;42(2):133-158. doi: 10.1159/000538434. eCollection 2024 Aug.

本文引用的文献

1
Incremental value of pulmonary function and sputum DNA image cytometry in lung cancer risk prediction.肺功能和痰液 DNA 图像细胞光度术在肺癌风险预测中的增量价值。
Cancer Prev Res (Phila). 2011 Apr;4(4):552-61. doi: 10.1158/1940-6207.CAPR-10-0183. Epub 2011 Mar 16.
2
The National Lung Screening Trial: overview and study design.国家肺癌筛查试验:概述与研究设计。
Radiology. 2011 Jan;258(1):243-53. doi: 10.1148/radiol.10091808. Epub 2010 Nov 2.
3
Evaluating health risk models.评估健康风险模型。
Stat Med. 2010 Oct 15;29(23):2438-52. doi: 10.1002/sim.3991.
4
Cancer statistics, 2010.癌症统计数据,2010 年。
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.
5
Chlamydia pneumoniae infection and risk for lung cancer.肺炎衣原体感染与肺癌风险。
Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1498-505. doi: 10.1158/1055-9965.EPI-09-1261. Epub 2010 May 25.
6
C-reactive protein and risk of lung cancer.C-反应蛋白与肺癌风险。
J Clin Oncol. 2010 Jun 1;28(16):2719-26. doi: 10.1200/JCO.2009.27.0454. Epub 2010 Apr 26.
7
Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates.国家癌症报告:1975-2006 年,重点介绍结直肠癌的流行趋势和干预措施(危险因素、筛查和治疗)对降低未来发病率的影响
Cancer. 2010 Feb 1;116(3):544-73. doi: 10.1002/cncr.24760.
8
A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma.一项肺癌全基因组关联研究确定了5号染色体p15区域与腺癌风险相关。
Am J Hum Genet. 2009 Nov;85(5):679-91. doi: 10.1016/j.ajhg.2009.09.012. Epub 2009 Oct 15.
9
Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer.慢性炎症、慢性阻塞性肺疾病和肺癌。
Curr Opin Pulm Med. 2009 Jul;15(4):303-7. doi: 10.1097/MCP.0b013e32832c975a.
10
Connective tissue-activating peptide III: a novel blood biomarker for early lung cancer detection.结缔组织激活肽III:一种用于早期肺癌检测的新型血液生物标志物。
J Clin Oncol. 2009 Jun 10;27(17):2787-92. doi: 10.1200/JCO.2008.19.4233. Epub 2009 May 4.

肺癌风险预测:前列腺癌、肺癌、结直肠癌和卵巢癌筛查试验模型及其验证。

Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation.

机构信息

Department of Community Health Sciences, Brock University, 500 Glenridge Ave, St Catharines, ON, Canada.

出版信息

J Natl Cancer Inst. 2011 Jul 6;103(13):1058-68. doi: 10.1093/jnci/djr173. Epub 2011 May 23.

DOI:10.1093/jnci/djr173
PMID:21606442
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3131220/
Abstract

INTRODUCTION

Identification of individuals at high risk for lung cancer should be of value to individuals, patients, clinicians, and researchers. Existing prediction models have only modest capabilities to classify persons at risk accurately.

METHODS

Prospective data from 70 962 control subjects in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) were used in models for the general population (model 1) and for a subcohort of ever-smokers (N = 38 254) (model 2). Both models included age, socioeconomic status (education), body mass index, family history of lung cancer, chronic obstructive pulmonary disease, recent chest x-ray, smoking status (never, former, or current), pack-years smoked, and smoking duration. Model 2 also included smoking quit-time (time in years since ever-smokers permanently quit smoking). External validation was performed with 44 223 PLCO intervention arm participants who completed a supplemental questionnaire and were subsequently followed. Known available risk factors were included in logistic regression models. Bootstrap optimism-corrected estimates of predictive performance were calculated (internal validation). Nonlinear relationships for age, pack-years smoked, smoking duration, and quit-time were modeled using restricted cubic splines. All reported P values are two-sided.

RESULTS

During follow-up (median 9.2 years) of the control arm subjects, 1040 lung cancers occurred. During follow-up of the external validation sample (median 3.0 years), 213 lung cancers occurred. For models 1 and 2, bootstrap optimism-corrected receiver operator characteristic area under the curves were 0.857 and 0.805, and calibration slopes (model-predicted probabilities vs observed probabilities) were 0.987 and 0.979, respectively. In the external validation sample, models 1 and 2 had area under the curves of 0.841 and 0.784, respectively. These models had high discrimination in women, men, whites, and nonwhites.

CONCLUSION

The PLCO lung cancer risk models demonstrate high discrimination and calibration.

摘要

简介

识别肺癌高危个体对个人、患者、临床医生和研究人员都具有重要意义。现有的预测模型在准确分类风险人群方面能力有限。

方法

使用前列腺癌、肺癌、结直肠癌和卵巢癌筛查试验(PLCO)中 70962 名对照受试者的前瞻性数据,建立一般人群模型(模型 1)和曾吸烟者亚组模型(模型 2)(N=38254)。两个模型均包含年龄、社会经济地位(教育)、体重指数、肺癌家族史、慢性阻塞性肺疾病、近期胸部 X 线、吸烟状况(从不、以前、现在)、吸烟年包数和吸烟持续时间。模型 2还包括戒烟时间(从不吸烟者永久戒烟后至今的年数)。利用完成补充问卷并随后进行随访的 44223 名 PLCO 干预组参与者进行外部验证。将已知的可用风险因素纳入逻辑回归模型。通过自举法计算预测性能的校正置信区间(内部验证)。年龄、吸烟年包数、吸烟持续时间和戒烟时间的非线性关系采用限制立方样条进行建模。所有报告的 P 值均为双侧。

结果

在对照组受试者的中位随访时间为 9.2 年期间,发生了 1040 例肺癌。在外部验证样本的中位随访时间为 3.0 年期间,发生了 213 例肺癌。模型 1 和模型 2 的自举法校正接收者操作特征曲线下面积分别为 0.857 和 0.805,校准斜率(模型预测概率与观察概率)分别为 0.987 和 0.979。在外部验证样本中,模型 1 和模型 2 的曲线下面积分别为 0.841 和 0.784。这些模型在女性、男性、白人和非白人中均具有较高的区分度。

结论

PLCO 肺癌风险模型具有较高的区分度和校准度。